$0.00
Register for Meetings
“In The News” & “Cardiovascular Marketplace” Content Access
Listen to Podcasts
Watch On-Demand Content
CardioTube Access
Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference
Access Recorded Interviews
Download PPT Slide Decks
$450 Annually
Complimentary subscription to electronic version of the CRM Journal
Access to CRT Meeting Registration Discounts
CRT Premium Content, including on-demand videos and presentation downloads
Nicole Lou Reporter, MedPage Today/CRTonline.org
CHICAGO — Compared with a surgical strategy, transcatheter aortic valve replacement (TAVR) using the new generation Sapien 3 device was tied to fewer adverse outcomes in intermediate-risk patients, according to a propensity-score analysis.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details